<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Expansions of trinucleotide repeats have been discovered in spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> (SCA) types 1, 2, 6, 7, 12, and 17, <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>), and dentatorubropallidoluysian <z:mpath ids='MPATH_127'>atrophy</z:mpath> (DRPLA) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the frequency of familial SCA in Japan remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>The number of trinucleotide repeats was determined for 1,286 patients </plain></SENT>
<SENT sid="3" pm="."><plain>Three hundred and thirty families (523 cases) were <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> group (A), and 165 families were positive for family history but not <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> group (B), while the remaining 598 cases were the <z:hpo ids='HP_0003745'>sporadic</z:hpo> group (C) </plain></SENT>
<SENT sid="4" pm="."><plain>The frequency of SCA subtypes in <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> group was: 1) 5.5% for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>; 2) 2.4% for SCA2; 3) 27.6% for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>; 4) 25.5% for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e>; 5) 0.3% for SCA17; and 6) 7.3% for DRPLA </plain></SENT>
<SENT sid="5" pm="."><plain>Abnormal expansion of SCA12 was not detected </plain></SENT>
<SENT sid="6" pm="."><plain>Another 31.5% of the patients in the <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> group had unknown genetic abnormalities </plain></SENT>
<SENT sid="7" pm="."><plain>Within group B, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> was the most prominent and within the <z:hpo ids='HP_0003745'>sporadic</z:hpo> group <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> were the most common subtypes observed </plain></SENT>
<SENT sid="8" pm="."><plain>The disease-free survival curve of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> was different from that of other SCAs and the mean age at <z:hpo ids='HP_0003674'>onset</z:hpo> for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> was found to be later than that of the other types </plain></SENT>
<SENT sid="9" pm="."><plain>Regional differences were observed in the relative rate of SCA subtypes </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> appears more common in the Kanto and Kyushu districts of Japan, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> is most common in the Chugoku district </plain></SENT>
<SENT sid="11" pm="."><plain>In order to establish an effective social welfare system for SCA patients, clinical course and regional differences in the prevalence of SCA subtypes must be taken into consideration </plain></SENT>
</text></document>